Search - tctmd.com

Displaying 321 - 340 of 1065

Sort: Relevancy | Date

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

November 24, 2021

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

November 23, 2021

COVID-19: TCTMD’s Dispatch for November Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 4

November 22, 2021

COVID-19: TCTMD’s Dispatch for November Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 3

November 15, 2021

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

News Daily News

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

November 11, 2021

COVID-19: TCTMD’s Dispatch for November Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 2

November 08, 2021

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

COVID-19: TCTMD’s Dispatch for November Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 1

November 01, 2021

Stimulants Linked to Early Risk of CV Events in Elderly

News Daily News

Stimulants Linked to Early Risk of CV Events in Elderly

Michael O'Riordan

October 25, 2021

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

News Daily News

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

October 20, 2021

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Diabetes Progression in Statin-Treated Patients: VA Data

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

October 05, 2021

Device-Detected AF Directly Linked to Ischemic Strokes

News Daily News

Device-Detected AF Directly Linked to Ischemic Strokes

October 04, 2021

COVID-19: TCTMD’s Dispatch for October Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 1

October 04, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 4

September 20, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.